Juan Li

Dr. Juan Li


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
QMQing Miao
Qing Miao
XSXiaopeng Shi
Xiaopeng Shi
MYMing-Xiang Ye
Ming-Xiang Ye
JZJin Zhang
Jin Zhang
SMShan Miao
Shan Miao
JZJian Zhang
Jian Zhang
Hypoxic pulmonary hypertension is a life-threatening emergency if untreated. Consistent pulmonary hypertension also leads to arteries and ventricular remodeling. The clinical therapeutic strategy for pulmonary hypertension and the corresponding remodeling mainly interacts with NO, angiotensin II (Ang II) and elevated endothelin (ET) targets. In the present study, we evaluated the effects of polydatin on hypoxia-induced pulmonary hypertension. It was observed that polydatin attenuated hypoxic pulmonary hypertension, reversed remodeling, and regulated NO, Ang II, ET contents in the serum and lung samples. However, forced activation of PKC signaling by its selective activator thymeleatoxin (THX) could abate the effects of polydatain. These results suggest that polydatin might be a promising candidate for hypoxic pulmonary treatment through interaction with PKC mechanisms.

20 May 2021 in Aging
Verified
Journal Article
Open access
JNJin Niu
Jin Niu
CWChen Wu
Chen Wu
MZMin Zhang
Min Zhang
ZYZhen Yang
Zhen Yang
ZLZhenhua Liu
Zhenhua Liu
JPJianming Pei
Jianming Pei
In the present study, the effects and mechanism of action of U50,488H (a selective κ-opioid receptor agonist) on calcification of rat vascular smooth muscle cells (VSMCs) induced by β-glycerophosphate (β-GP) were investigated. VSMCs were isolated and cultured in traditional FBS-based media. A calcification model was established in VSMCs under hyperphosphatemia and intracellular calcium contents. Alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and lactate were detected in cell culture supernatants before and after treatment. Alizarin red staining was used to detect the degree of calcification of VSMCs. Expression levels of key molecules of osteogenic markers, fructose-2,6-biphosphatase 3 (PFKFB3), and proline hydroxylase 2 (PHD2), were determined using western blotting. Further, vascular calcification was induced by vitamin D3 plus nicotine in rats and isolated thoracic aortas, calcium concentration was assessed in rat aortic rings in vitro. We demonstrated that U50,488H inhibited VSMC calcification in a concentration-dependent manner. Moreover, U50,488H significantly inhibited osteogenic differentiation and ALP activity in VSMCs pretreated with β-GP. Further studies confirmed that PFKFB3 expression, LDH level, and lactate content significantly increased during calcification of VSMCs; U50,488H reversed these changes. PHD2 expression showed the opposite trend compared to PFKFB3 expression. nor-BNI or 3-PO abolished U50,488H protective effects. Besides, U50,488H inhibited VSMC calcification in rat aortic rings ex vivo. Collectively, our experiments show that κ-opioid receptor activation inhibits VSMC calcification by reducing PFKFB3 expression and lactate content, providing a potential drug target and strategy for the clinical treatment of vascular calcification.

1 October 2023 in Vascular Health and Risk Management
Verified
Journal Article
Open access
PDF file
GLGuofang Lu
Guofang Lu
RDRui Du
Rui Du
YLYali Liu
Yali Liu
SZShumiao Zhang
Shumiao Zhang
JLJuan Li
Juan Li
JPJianming Pei
Jianming Pei
Introduction: Pulmonary arterial hypertension (PAH) is a life-threatening disease characterized by a sustained rise in mean pulmonary artery pressure. Pulmonary vascular remodeling serves an important role in PAH. Identifying a key driver gene to regulate vascular remodeling of the pulmonary microvasculature is critical for PAH management. Methods: Differentially expressed genes were identified using the Gene Expression Omnibus (GEO) GSE117261, GSE48149, GSE113439, GSE53408 and GSE16947 datasets. A co-expression network was constructed using weighted gene co-expression network analysis. Novel and key signatures of PAH were screened using four algorithms, including weighted gene co-expression network analysis, GEO2R analysis, support vector machines recursive feature elimination and robust rank aggregation rank analysis. Regulator of G-protein signaling 5 (RGS5), a pro-apoptotic/anti-proliferative protein, which regulate arterial tone and blood pressure in vascular smooth muscle cells. The expression of RGS5 was determined using reverse transcription-quantitative PCR (RT-qPCR) in PAH and normal mice. The location of RGS5 and pericytes was detected using immunofluorescence. Results: Compared with that in the normal group, RGS5 expression was upregulated in the PAH group based on GEO and RT-qPCR analyses. RGS5 expression in single cells was enriched in pericytes in single-cell RNA sequencing analysis. RGS5 co-localization with pericytes was detected in the pulmonary microvasculature of PAH. Conclusion: RGS5 regulates vascular remodeling of the pulmonary microvasculature and the occurrence of PAH through pericytes, which has provided novel ideas and strategies regarding the occurrence and innovative treatment of PAH.

28 April 2022 in Human Mutation
Verified
Journal Article
Closed access
JLJuan Li
Juan Li
YYYu Yuan
Yu Yuan
CLChaorong Liu
Chaorong Liu
YXYuchen Xu
Yuchen Xu
NXNeng Xiao
Neng Xiao
LLLili Long
Lili Long

23 November 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
GLGuofang Lu
Guofang Lu
RDRui Du
Rui Du
LLLinhe Lu
Linhe Lu
QWQiaojuan Wang
Qiaojuan Wang
MZMin Zhang
Min Zhang
JPJianming Pei
Jianming Pei

18 May 2018 in European Journal of Pharmacology
Verified
Journal Article
Closed access
YZYaguang Zhou
Yaguang Zhou
XTXin Tian
Xin Tian
XWXueying Wang
Xueying Wang
YWYuanbo Wang
Yuanbo Wang
RFRong Fan
Rong Fan
JPJianming Pei
Jianming Pei